Most glucagon-like peptide-1 receptor agonist medications reduce a likelihood of depression and anxiety diagnoses
Leo Sher, M.D. A research report, “Most GLP-1 medications correlated with a lower likelihood of anxiety and depression diagnoses” was published in Epic Research on February 6, 2024 (1). Glucagon-like peptide-1 receptor agonist (GLP-1) medications are used for glucose control in diabetic patients and for weight management in obese patients. The authors studied the potential […]